{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T19:29:20Z","timestamp":1773084560085,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"15-16","license":[{"start":{"date-parts":[[2001,2,1]],"date-time":"2001-02-01T00:00:00Z","timestamp":980985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2001,2]]},"DOI":"10.1016\/s0264-410x(00)00433-3","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T19:54:37Z","timestamp":1027626877000},"page":"1940-1950","source":"Crossref","is-referenced-by-count":102,"title":["Protection against Bordetella pertussis infection following parenteral or oral immunization with antigens entrapped in biodegradable particles: effect of formulation and route of immunization on induction of Th1 and Th2 cells"],"prefix":"10.1016","volume":"19","author":[{"given":"Margaret A.","family":"Conway","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Madrigal-Estebas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siobhan","family":"McClean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Brayden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kingston H.G.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0264-410X(00)00433-3_BIB1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/jbm.820190315","article-title":"Biogradation and tissue reaction to 50:50 poly (d, l-lactide-co-glycolide)","volume":"19","author":"Visscher","year":"1985","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/S0264-410X(00)00433-3_BIB2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0168-3659(94)90160-0","article-title":"Biodegradable microspheres for the delivery of oral vaccines","volume":"28","author":"Mestecky","year":"1994","journal-title":"J. Controlled Release"},{"key":"10.1016\/S0264-410X(00)00433-3_BIB3","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1126\/science.8493576","article-title":"Protection against vaginal SIV transmission with microencapsulated vaccine","volume":"260","author":"Marx","year":"1993","journal-title":"Science"},{"key":"10.1016\/S0264-410X(00)00433-3_BIB4","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0264-410X(96)00077-1","article-title":"Single dose, polymeric microparticle-based vaccines: the influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen","volume":"14","author":"Coombes","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/S0264-410X(00)00433-3_BIB5","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/0264-410X(95)00184-3","article-title":"Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells","volume":"13","author":"Moore","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/S0264-410X(00)00433-3_BIB6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0065-2776(08)60240-0","article-title":"Immunoglobulin A (IgA); molecular and cellular interactions involved in IgG biosynthesis and immune response","volume":"40","author":"Mestecky","year":"1987","journal-title":"Adv. Immunol."},{"key":"10.1016\/S0264-410X(00)00433-3_BIB7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0891-5520(20)30344-5","article-title":"In defense of mucosal surfaces. Development of novel vaccines for IgA responses protective at the portals of entry of microbial pathogens","volume":"4","author":"McGhee","year":"1990","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"10.1016\/S0264-410X(00)00433-3_BIB8","first-page":"13","article-title":"Overview of the mucosal immune system","volume":"146","author":"Brandtzaeg","year":"1989","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/S0264-410X(00)00433-3_BIB9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0168-3659(90)90133-E","article-title":"Controlled vaccine release in the gut associated lymphoid tissues. 1. Orally administered biodegradable microspheres target the Peyer's patches","volume":"11","author":"Eldridge","year":"1990","journal-title":"J. Controlled Release"},{"key":"10.1016\/S0264-410X(00)00433-3_BIB10","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/aja.1001360406","article-title":"Pinocytosis by epithelium associated with lymphoid follicles in the bursa of Fabricius, appendix and Peyer's patches. An electron microscopic study","volume":"136","author":"Blockman","year":"1973","journal-title":"Am. J. Anat."},{"key":"10.1016\/S0264-410X(00)00433-3_BIB11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0169-409X(90)90020-S","article-title":"Intestinal translocation of particulates-implications for drug and antigen delivery","volume":"5","author":"O'Hagan","year":"1990","journal-title":"Adv. Drug Delivery Rev."},{"key":"10.1016\/S0264-410X(00)00433-3_BIB12","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1128\/IAI.66.2.594-602.1998","article-title":"A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis","volume":"66","author":"Mills","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/S0264-410X(00)00433-3_BIB13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1099\/00222615-39-3-163","article-title":"Cellular immunity in pertussis","volume":"39","author":"Mills","year":"1993","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/S0264-410X(00)00433-3_BIB14","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1086\/593682","article-title":"Bordetella pertussis respiratory infection in children is associated with preferential activation of type1 T helper cells","volume":"175","author":"Ryan","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/S0264-410X(00)00433-3_BIB15","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1128\/IAI.61.8.3190-3198.1993","article-title":"Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity","volume":"61","author":"Redhead","year":"1993","journal-title":"Infect. Immun."},{"key":"10.1016\/S0264-410X(00)00433-3_BIB16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2567.1998.00401.x","article-title":"Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children","volume":"93","author":"Ryan","year":"1998","journal-title":"Immunology"},{"key":"10.1016\/S0264-410X(00)00433-3_BIB17","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1128\/IAI.65.6.2168-2174.1997","article-title":"Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines","volume":"65","author":"Ausiello","year":"1997","journal-title":"Infect. Immun."},{"key":"10.1016\/S0264-410X(00)00433-3_BIB18","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJM199602083340601","article-title":"A controlled trial of a two acellular vaccines and one whole cell vaccine against pertussis","volume":"334","author":"Greco","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/S0264-410X(00)00433-3_BIB19","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJM199602083340602","article-title":"A controlled trial of two-component acellular, a five-component acellular and a whole cell pertussis vaccine","volume":"334","author":"Gustafsson","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/S0264-410X(00)00433-3_BIB20","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJM199510193331604","article-title":"A placebo-controlled trial of a pertussis-toxid vaccine","volume":"333","author":"Trollofors","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/S0264-410X(00)00433-3_BIB21","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.2042-7158.1995.tb06713.x","article-title":"Particle size studies for subcutaneous delivery of poly (lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation","volume":"47","author":"Uchida","year":"1994","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/S0264-410X(00)00433-3_BIB22","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0264-410X(94)00026-J","article-title":"Dependence of ricin toxoid vaccine efficacy on the structure of poly(lactide-co-glycolide) microparticle carriers","volume":"13","author":"Yan","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/S0264-410X(00)00433-3_BIB23","unstructured":"Brady J, Ramtoola Z. In vitro and in vivo characterization of herparin-loaded microspheres. In: Courveur P, Duchene D, Kalles I, editors. Formulation of poorly available drugs for oral administration. Editions de Sante, 1996. p. 347\u201350."},{"key":"10.1016\/S0264-410X(00)00433-3_BIB24","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1023\/A:1018980020506","article-title":"Preparation and characterization of poly(lactide-co-glycolide) microparticles. II. Protein entrapment by water-in-oil emulsion solvent evaporation","volume":"10","author":"Jeffrey","year":"1993","journal-title":"Pharm. Res."},{"key":"10.1016\/S0264-410X(00)00433-3_BIB25","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1128\/IAI.61.2.399-410.1993","article-title":"Cell mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model","volume":"61","author":"Mills","year":"1993","journal-title":"Infect. Immun."},{"key":"10.1016\/S0264-410X(00)00433-3_BIB26","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1084\/jem.186.11.1843","article-title":"Atypical disease following Bordetella pertussis respiratory infection of mice with target disruptions in IFN-\u03b3 receptor or immunoglobin \u03bc chain genes","volume":"186","author":"Mahon","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0264-410X(00)00433-3_BIB27","doi-asserted-by":"crossref","unstructured":"Mahon BP, Brady MT, Mills KHG. Protection against Bordetella pertussis in mice in the absence of detectable circulating antibody: implications for long term immunity in children, J Infect Dist 181, 2087\u20132091.","DOI":"10.1086\/315527"},{"key":"10.1016\/S0264-410X(00)00433-3_BIB28","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1089\/aid.1992.8.1765","article-title":"The control of the antibody isotype response to human immunodeficiency virus gp120 antigen by adjuvants","volume":"8","author":"Bomford","year":"1992","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/S0264-410X(00)00433-3_BIB29","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.4049\/jimmunol.146.6.1750","article-title":"Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen presenting populations","volume":"146","author":"Gajewski","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/S0264-410X(00)00433-3_BIB30","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.4049\/jimmunol.149.11.3468","article-title":"IL-4 synthesis by in vivo primed keyhole limpet hemocyanin-specific CD4+ T cells. I. Influence of antigen concentration and antigen-presenting cell type","volume":"149","author":"DeKruff","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/S0264-410X(00)00433-3_BIB31","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1006\/cimm.1993.1279","article-title":"The role of antigen presenting cells in the regulation of delayed type hypersensitivity. II Epidermal Langerhans\u2019 cells and peritoneal exudate macrophages","volume":"150","author":"Morikawa","year":"1993","journal-title":"Cell Immunol."},{"key":"10.1016\/S0264-410X(00)00433-3_BIB32","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0264-410X(94)00008-B","article-title":"Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles","volume":"13","author":"Cahill","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/S0264-410X(00)00433-3_BIB33","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/1521-4141(200002)30:2<415::AID-IMMU415>3.0.CO;2-X","article-title":"Direct anti-inflammatory effect of a bacterial virulence factor: IL-10-dependent suppression of IL-12 production by filamentous hemagglutinin from Bordetella pertussis","volume":"30","author":"McGuirk","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/S0264-410X(00)00433-3_BIB34","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/336070a0","article-title":"B cell memory is short lived in the absence of antigen","volume":"36","author":"Gray","year":"1988","journal-title":"Nature"},{"key":"10.1016\/S0264-410X(00)00433-3_BIB35","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1128\/IAI.64.2.489-494.1996","article-title":"Orally administered microencapsulated Bordetella pertussis Fimbriae protect mice from B. pertussis respiratory infection","volume":"64","author":"Jones","year":"1996","journal-title":"Infect. Immun."},{"key":"10.1016\/S0264-410X(00)00433-3_BIB36","first-page":"164","article-title":"Enchanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable particles containing antigen","volume":"76","author":"Challacombe","year":"1992","journal-title":"Immunology"},{"key":"10.1016\/S0264-410X(00)00433-3_BIB37","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1084\/jem.134.1.188","article-title":"Peyer's patches: an enriched source of precursors for IgA-producing immunocytes in the rabbit","volume":"134","author":"Craig","year":"1971","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0264-410X(00)00433-3_BIB38","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1084\/jem.130.4.723","article-title":"Antibodies of the IgA isotype in intestinal plasma cells of germ-free mice after oral or parenteral immunization with ferritin","volume":"30","author":"Crabbe","year":"1969","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0264-410X(00)00433-3_BIB39","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.4049\/jimmunol.105.4.1049","article-title":"Predominant contribution of IgA antibody-forming cells to an immune response detected in extraintestinal lymphoid tissues of germ-free mice exposed to antigen by the oral route","volume":"105","author":"Bazin","year":"1970","journal-title":"J. Immunol."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X00004333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X00004333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T21:44:17Z","timestamp":1681335857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X00004333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,2]]},"references-count":39,"journal-issue":{"issue":"15-16","published-print":{"date-parts":[[2001,2]]}},"alternative-id":["S0264410X00004333"],"URL":"https:\/\/doi.org\/10.1016\/s0264-410x(00)00433-3","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2001,2]]}}}